Adhesion Prevention

0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Sanofi
SanofiPARIS, France
1 program
SeprasprayN/A3 trials
Active Trials
NCT00778479Terminated155Est. May 2009
NCT00813397Completed210Est. Jul 2009
NCT00624390Completed41Est. Dec 2008

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SanofiSepraspray
SanofiSepraspray
SanofiSepraspray

Clinical Trials (3)

Total enrollment: 406 patients across 3 trials

Evaluation of the Safety of Sepraspray in Open Abdominal Surgery

Start: Oct 2008Est. completion: May 2009155 patients
N/ATerminated

Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.

Start: Sep 2008Est. completion: Jul 2009210 patients
N/ACompleted

Sepraspray™ Laparoscopic Myomectomy Study

Start: Nov 2007Est. completion: Dec 200841 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space